Cargando…
Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients
COVID-19 pandemic exerts a health care emergency around the world. The illness severity is heterogeneous. It is mostly unknown why some individuals who are positive for SARS-CoV-2 antibodies stay asymptomatic while others show moderate to severe disease symptoms. Reliable biomarkers for early detect...
Autores principales: | Janneh, Alhaji H., Kassir, Mohamed Faisal, Dwyer, Connor J., Chakraborty, Paramita, Pierce, Jason S., Flume, Patrick A., Li, Hong, Nadig, Satish N., Mehrotra, Shikhar, Ogretmen, Besim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270895/ https://www.ncbi.nlm.nih.gov/pubmed/34244584 http://dx.doi.org/10.1038/s41598-021-93857-7 |
Ejemplares similares
-
Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment
por: Janneh, Alhaji H., et al.
Publicado: (2022) -
Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T cell response
por: Vaena, Silvia, et al.
Publicado: (2021) -
Comparative analysis of antibodies to SARS-CoV-2 between asymptomatic and convalescent patients
por: Dwyer, Connor J., et al.
Publicado: (2021) -
Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis
por: Janneh, Alhaji H., et al.
Publicado: (2022) -
CD38-NAD(+)-Sirt1 axis in T cell immunotherapy
por: Chatterjee, Shilpak, et al.
Publicado: (2019)